Search results
Results from the WOW.Com Content Network
Phage therapy is the use of bacteriophages to treat bacterial infections. Bacteriophage treatment offers a possible alternative to conventional antibiotic treatments for bacterial infection. [55] It is conceivable that, although bacteria can develop resistance to phages, the resistance might be easier to overcome than resistance to antibiotics.
In July 2007, the same bacteriophage were approved for use on all food products. [37] In 2011 USDA confirmed that LISTEX is a clean label processing aid and is included in USDA. [38] Research in the field of food safety is continuing to see if lytic phages are a viable option to control other food-borne pathogens in various food products. [39]
The center was founded by Steffanie A. Strathdee and Robert "Chip" Schooley, both professors at UC San Diego School of Medicine. The center currently treats patients with life-threatening multi-drug resistant infections with phage therapy, on a case-by-case basis, through the Food and Drug Administration's (FDA's) compassionate use program.
Mycobacteriophage Bxb1 Structure [1]. A mycobacteriophage is a member of a group of bacteriophages known to have mycobacteria as host bacterial species. While originally isolated from the bacterial species Mycobacterium smegmatis and Mycobacterium tuberculosis, [2] the causative agent of tuberculosis, more than 4,200 mycobacteriophage species have since been isolated from various environmental ...
Raiga, A. 1941. Traitement des Plaies de Guerre par le Bactériophage de d'Hérelle . Legrand & Bertrand, Paris. [French; Treatment of the wounds of war by the bacteriophage of Hérelle] OCLC 14725592; Tsulukidze, A.P. 1941. Experience of Use of Bacteriophages in the Conditions of War Traumatism. Russian? Gruzmedgiz, Tbilisi, Georgia.
A more detailed account of the use of phage in major biological discoveries can be found on the page, bacteriophage. As one of the earliest applied microbiologists, d'Hérelle's microbe-centered worldview has been noted for its prescience, since microbes are playing increasingly important roles in bioremediation , microbial fuel cells , gene ...
Eliava got excited about the potential of bacteriophages in medical applications, and brought the research (and, eventually, d'Hérelle), to Tbilisi. In 1923, Eliava founded a bacteriological institute in Tbilisi on the basis of the laboratory he headed since 1921, to research and promote phage therapy .
Phage display cycle. 1) fusion proteins for a viral coat protein + the gene to be evolved (typically an antibody fragment) are expressed in bacteriophage. 2) the library of phage are washed over an immobilised target. 3) the remaining high-affinity binders are used to infect bacteria. 4) the genes encoding the high-affinity binders are isolated.